OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
MEDIF
Medipharm Labs Corporation
Ordinary Shares
0.06462
0.00
0.00%
0.06 / 0.0632 (10000 x 49000)
Real-Time Best Bid & Ask: 09:47am 06/16/2025
Delayed (15 Min) Trade Data: 12:00am 06/13/2025
0.00
N/A
30
Market Cap calculated only for this class of securities.
26,826,280
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
VIRTU Americas LLC | 0.06 | 10,000 | 09:37 |
OTC NQB | 0.0594 | 12,000 | 09:47 |
Virtu Americas LLC | 0.0585 | 25,000 | 09:48 |
GTS Securities LLC | 0.0575 | 10,000 | 06:59 |
Citadel Securities | 0.0541 | 20,000 | 09:30 |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
OTC NQB | 0.0635 | 49,000 | 09:48 |
Virtu Americas LLC | 0.0636 | 25,000 | 09:48 |
GTS Securities LLC | 0.0665 | 10,000 | 06/10 |
G1 Execution Services, LLC | 0.068 | 10,000 | 09:32 |
MCAP LLC | 0.0793 | 10,000 | 09:46 |
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 06/13/2025 | 15:58:58 | 0.06462 | -0.00 | 1,200 |
| 06/13/2025 | 15:58:09 | 0.0649 | 0.00 | 1,200 |
| 06/13/2025 | 14:29:02 | 0.0607 | -0.00 | 1,000 |
| 06/13/2025 | 14:21:42 | 0.06085 | 0.00 | 1,000 |
| 06/13/2025 | 14:18:46 | 0.0584 | -0.00 | 200 |
News
MediPharm Reminds Shareholders to Vote in Advance of June 13 DeadlineGlobeNewswire | 06/11/2025
Filings and Disclosure
Company Description
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its customers. Through its wholesale and white label platforms, MediPharm Labs formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. In 2021, MediPharm Labs received a Pharmaceutical Drug Establishment Licence from Health Canada, becoming the only company in North America to hold a domestic Good Manufacturing Licence for the extraction of natural cannabinoids. MediPharm carries out its operations in compliance with all applicable laws in the countries in which it operates.
Videos
This company has not added any videos
Joined OTCQB 05/2023
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
51.15
Change
0.00 (0.00%)
Bid
50.75
Ask
51.15
Volume
475
Time
00:00
